BioSpace News Archive

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, announced today that it has entered into a Research Agreement with Mayo Clinic to test and validate its patented Bio-RFID™ platform technology.

Nexa3D, the maker of ultrafast stereolithography production 3D printers, and Henkel, a leading supplier of high impact functional additive materials, announced today the immediate commercial availability of xMED412, a polypropylene-like material that is ideal for manufacturing a variety of biocompatible, medical and wearable devices.

Nuclera, a Cambridge, UK-based biotech company developing benchtop gene and protein printing technologies, is pleased to announce that Dr Joe Keegan has been appointed to its Board as Non-executive Director.

Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2020 financial results before the open of the market on Tuesday, August 4, 2020. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin, Chief Financial Officer, will host a conference call to review the Company’s financial results at 8:00 a.m

AbCellera Announces Agreement with Alloy Therapeutics to Integrate Access to ATX-Gx ™ Humanized Mice Platform for Antibody Discovery Programs By using humanized rodents as a source of diversity, AbCellera’s platform provides partners with the fastest path to large panels of high-quality fully human antibodies

Software veteran Amanda Buckley joins as Chief Operating Officer

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a worldwide reputation for top-rated customer service and support, today announced that its Ortho Care™ holistic service and support program was ranked No. 1 in the diagnostics industry for a fifth straight year.

BioReference Laboratories, Inc., an OPKO Health company, announced that Geoff Monk, President of BioReference Laboratories, was recognized by CEO Today Magazine as one of this year’s 20 Healthcare Award winners.

First-of-its-kind nonprofit to leverage case management and referral technology to drive better care and lower costs for communities in need

Triplet Therapeutics, Inc., a biotechnology company leveraging insights from the human genetics of repeat expansion disorders (REDs), announced today the selection of TTX-3360 as the first clinical candidate developed from Triplet’s proprietary thRED Engine. TTX-3360, an antisens